Generate a tailored SOP for Dr. Rachel Perry. Improve your application with a focused, well-structured draft.
Rachel Jamison Perry is an Associate Professor in the Department of Cellular & Molecular Physiology at Yale University School of Medicine with additional appointments in Comparative Medicine and Neuroscience. She focuses on the role of metabolism in cancer, particularly how obesity and insulin levels influence tumor growth. Dr. Perry utilizes hyperinsulinemic-euglycemic clamps and stable isotope infusions to assess insulin sensitivity and metabolic flux pathways. She has received funding from prominent organizations, including the NIH and the Melanoma Research Alliance. Rachel has mentored high school, undergraduate, and graduate students, promoting diversity and equity in training environments. Her laboratory is engaged in various projects aimed at understanding the molecular mechanisms by which obesity and hyperinsulinemia affect tumor metabolism and immunology. She is committed to both research excellence and mentorship, constantly striving to enhance the academic experience for her trainees.
Yale University School of Medicine • New Haven, CT
Conducts research on tumor metabolism and the impact of systemic metabolism.
Vivo Physiology Core, Yale Mouse Metabolic Phenotyping Center • New Haven, CT
Oversees the Vivo Physiology Core and manages resources for metabolic studies.
Cancer Research Training & Education Coordination • New Haven, CT
Assists in the coordination of cancer research training and educational programs.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.